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INTRODUCTION
The aim of conscious sedation in gastrointestinal endoscopy
is to promote the patient’s tolerance and cooperation. Thus,
the clinical end-points for sedation should aim for amnesia,
anxiolysis, and cooperation rather than hypnosis (1). Although
propofol provides faster onset and deeper sedation than stan-
dard benzodiazepines, clinically important benefits have not
been consistently demonstrated in average-risk patients under-
going standard upper and lower gastrointestinal endoscopy
(2). Besides, intravenous midazolam has been proven to give
the best results in gastrointestinal endoscopy due to its safety,
rapid onset, shorter duration of action, anxiolysis, and amne-
sia (3). In addition, opiates provide analgesia, produces syn-
ergistic sedation with midazolam, and increase amnesia and
patient satisfaction (4). Therefore, gastrointestinal endoscopy
is still often performed under moderate sedation with ben-
zodiazepine and narcotics.
The use of conscious sedation is widespread presently, and
results in a high degree of satisfaction with the procedure by
both patients and physician (3, 4). However, there is no well-
defined set of practice guidelines that can be used to determine
which patients can undergo successful conscious sedation in
gastrointestinal endoscopy. By determining the predictive
clinical variables, patients scheduled for gastrointestinal endo-
scopic examination will be ensured of the optimal use of seda-
tion. In addition, the identification of clinical variables in
conscious sedation would contribute to better satisfaction for
both patients and endoscopists. Here, we identified the clin-
ical variables of successful conscious sedation in the Korean
population by using multivariate analysis.
MATERIALS AND METHODS
Study population 
This prospective study was conducted in a single health
promotion center at Samsung Medical Center, Seoul, Korea.
From November 2002 to February 2003, a total of 300 adult
subjects who were scheduled to undergo diagnostic gastroin-
testinal endoscopy for routine examination were prospectively
considered. Because the intention was to sedate, those who
prefered not to be sedated were excluded from the study. We
also excluded those who had recently taken medications such
as benzodiazepines, opioids, barbiturates, and antihistamines
because these drugs influence conscious sedation (5). In addi-
tion, those who had diagnosed as psychological disease includ-
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Identification of Factors that Influence Conscious Sedation in
Gastrointestinal Endoscopy
Although several studies examined factors that influence conscious sedation, inves-
tigation was limited into the gender and age. The aim of this prospective study is to
identify the clinical variables of successful conscious sedation during gastrointestinal
endoscopy. A total of 300 subjects who underwent gastrointestinal endoscopy were
enrolled in a prospective fashion. They completed a questionnaire to assess height,
weight, drinking, smoking, education level, recent medication, past medical history,
previous experience of conscious sedation, preprocedural anxiety, and apprehen-
sion about the procedure. Efficacy of sedation and amnesia were evaluated by the
subject and the endoscopist. Amnesic and sedative effects were proportionally relat-
ed with age (p<0.0001). Preprocedural anxiety level was higher in women (p=0.0062),
younger subjects (p=0.035), slender subjects (p=0.041), and in those without pre-
vious experience of conscious sedation (p=0.0034). This anxiety level was also
related to increased pain (p=0.0026) and alertness (p=0.0003) during the procedure.
Lower dose of midazolam is needed for sedation in older subjects. Subjects with a
high level of preprocedural anxiety such as women, younger subjects, slender sub-
jects, and those without previous experience of conscious sedation should be sedat-
ed with great caution because generally, they complain of much more severe pain
and alertness during the procedure. 
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ing dementia and those with severe comorbid disease greater
than American Society of Anesthesiology (ASA) preoperative
patient classification III were excluded from the study (6). The
study protocol was approved by the Ethics Committee of
Samsung Medical Center, and each study participant signed
an informed consent.
Endoscopic procedure
Consistent with routine practice, subjects received lidocaine
anesthetic spray in a standard fashion. In the endoscopy room,
all the subjects had an intravenous access for midazolam 0.07
mg/kg and pethidine 25 mg injection to achieve conscious
sedation. After the injection, subjects were monitored for
oxygen saturation, heart rate, blood pressure, and respiratory
rate. Each subject underwent standard diagnostic upper gas-
trointestinal endoscopy (GIF-XQ 240, Olympus optical Co.
Ltd, Tokyo, Japan) with or without sigmoidoscopy (CF 200S,
Olympus optical Co. Ltd, Tokyo, Japan). In cases with sig-
moidoscopy, the subjects ingested Magcorol 250 mL (mag-
nesium carbonate 10.75 g with anhydrous citric acid 19.5 g;
Taejoon, Seoul, Korea) 12 hr before the examination. Endo-
scopic procedure was performed by one of the four attending
endoscopists with an endoscopic assistant nurse. Sigmoido-
scopy was performed immediately after upper gastrointesti-
nal endoscopic examination.
Data collection
Data collection was completed by the subjects and the endo-
scopists. Because the adequacy of sedation estimated by the
endoscopist does not always correlate with the subjects’ own
perception, we approached the subject and the endoscopist
blindly to each other. Before the application of intravenous
midazolam injection, subjects were required to memorize
two words, airplane and apple. After the procedure, all of the
subjects completed a questionnaire (Table 1-1). Previous expe-
rience of conscious sedation (in the questionnaire) included
during either the intraabdominal operation or endoscopy. 
The efficacy of the sedation was reported by visual analogue
scale (VAS) (7). The endoscopist completed a questionnaire
about the degree of cooperation (0 extremely poor-100 excel-
lent) and sedation (0 full sedation-100 alert) during the proce-
dure. In addition, the subjects were asked to recall two words
which they have heard prior to sedation (Table 1-2). This two
word test was performed a total of three times in each subject;
30 sec after midazolam injection, immediately after the pro-
cedure, and 30 min after the procedure. 
Statistical analyses
Statistical analyses were done using SPSS software 10.0 and
a p-value less than 0.05 was considered significant. The data
were reported as mean  standard deviation (SD) for continu-
ous variables and percentage with 95% confidence interval
(CI) for categorical variables. Multivariate analysis was per-
formed with 11 factors (age, gender, body mass index, drink-
ing, smoking, education level, past experience of conscious
sedation, type of procedure, total time of procedure, midazo-
lam dose, and biopsy status) to identify clinical predictors of
the main outcome (two word test, consciousness, cooperation,
retching, behavioral interruption, and pain) as well as prepro-
cedural status (anxiety and apprehension about the procedure).
Table 1-1. Data collection by the subject
Name:  (                            )
Gender:  (   ) Male   (   ) Female
Date of Birth:  (                            )
Height/Weight:  (   ) cm/(   ) kg
Do you drink more than 40 g a day?  (   ) Yes   (   ) No
Are you an active smoker?  (   ) Yes   (   ) No
Indicate the highest education level you have completed.
(   ) Elementary   (   ) Middle   (   ) High   (   ) College/university
(   ) Postgraduate
Please list all your recent medications:  (                                                )
Please list your current health problem:  ( )
Have you ever had a conscious sedation before?  (   ) Yes   (   ) No
Do you remember the procedure?  (   ) Yes   (   ) No
Check your self-perceived pain with    during the procedure.
0       10       20       30       40       50       60       70       80       90       100
No pain                                  Moderate                                 Unbearable
Rate your preprocedural anxiety level with    .
0       10       20       30       40       50       60       70       80       90       100
Not anxious                        Intermediate                              Very anxious
Did you easily understand the introduction about the procedure?
(   ) No, I didn’t   (   ) So so   (   ) Yes, I did
Subject’s name:  (                            )
How long did the procedure take?  (   ) minutes   (   ) seconds
What type of procedure?
(   ) Gastroscopy   (   ) Gastroscopy with sigmoidoscopy
Did you perform biopsy during the procedure?  (   ) Yes   (   ) No
Dose of the midazolam:  (           ) mg
Check the subject’s level of consciousness with    during the procedure.
0       10       20       30       40       50       60       70       80       90       100
Full sedation                          Moderate                                             Alert
Rate the subject’s level of cooperation with    during the procedure.
0       10       20       30       40       50       60       70       80       90       100
Poor cooperation                  Intermediate                                 Excellent
Check the subject’s degree of retching during the procedure.
(   ) Severe   (   ) Moderate   (   ) Mild or none
Did the subject's behavior interrupt the procedure?  (   ) Yes   (   ) No
Check the number of words the subject has recalled in the following
periods: 
① 30 seconds after midazolam injection:  (   ) 0   (   ) 1   (   ) 2
② Immediately after the procedure:  (   ) 0   (   ) 1   (   ) 2
③ Immediately after the procedure:  (   ) 0   (   ) 1   (   ) 2
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One significant variable (self perceived preprocedural anxiety
level) was analyzed by Wilcoxon’s two sample test. Spearman’s
correlation test was used to measure the correlation between
two variables expressed as categories. 
RESULTS
All 300 subjects completed a questionnaire after the pro-
cedure. There was no significant side effect such as oxygen
desaturation and life-threatening cardiac arrhythmia. The
distribution of subject’s variables and procedural variables
are summarized in Table 2. 
Preprocedural status as assessed by the subject revealed
that the degree of preprocedural anxiety level was higher in
younger subjects (p=0.035), in slender subjects (p=0.041),
in women (Wilcoxon’s value=2.74, p=0.0062), and in those
without previous history of conscious sedation (Wilcoxon’s
value=2.96, p=0.030). However, preprocedural anxiety was
not related to drinking, smoking, or education level. 
Efficacy of the sedation achieved by the endoscopist and
the subject are summarized in Table 3. Impact of sedation
as assessed by the endoscopist revealed that the degree of con-
sciousness was lower in older subjects (p<0.0001). Degree of
amnesia achieved by subjects revealed that older subjects were
poor in remembering the procedure (Table 4). In contrast,
those who were biopsied during the procedure remembered
the procedure much better (p=0.049). In addition, those who
underwent sigmoidoscopy with gastroscopy (p=0.032) were
relatively alert than those who underwent gastroscopy alone.
Factor By the endoscopist By the subject
Age (yr) Decreased consciousness in elder subjects (p<0.0001) Increased pain in younger subjects (p=0.0004)
Gender Increased consciousness in women (p=0.0062) NS (p=0.35)
Body mass index Increased irritability in slender subjects (p=0.0495) NS (p=0.93)
Drinking NS (p=0.74) NS (p=0.68)
Smoking NS  (p=0.68) NS (p=0.66)
Education level NS (p=0.85) NS (p=0.36)
Experience of sedation NS (p=0.50) Increased pain in subjects without experience of  
sedation (p=0.030)
Type of procedure Increased consciousness in subjects with sigmoidoscopy  NS (p=0.20)
(p=0.032)
Duration of  procedure  Increased consciousness in subjects with longer duration  NS (p=0.61)
(p=0.026)
Midazolam dose Decreased consciousness in higher dose (p=0.048) NS (p=0.50)
Biopsy status NS (p=0.31) Improved recollection in subjects with biopsy
(p=0.049)
Table 3. Efficacy of the sedation achieved by the endoscopist and the subject 
NS, no statistically significant relationship.
Factors Data
Age* (yr) 48.3±8.8
Male sex; No. (%) 178 (59.3)
Body mass index*; kg/m
2 23.8±2.8 
Drink more than 40 g a day; No. (%) 111 (37)
Active daily smoker; No. (%) 77 (25.7)
Final education; No. (%)
Postgraduate school 47 (15.7)
College or university 162 (54)
High school 75 (25)
Middle school 8 (2.7)
Elementary school 5 (1.7)
No comment 3 (1)
Past history of conscious sedation; No. (%) 163 (54.3)
Type of procedure 
Gastroscopy only; No. (%) 121 (59.7)
Gastroscopy with sigmoidoscopy; No. (%) 179 (59.7)
Total procedure time*; min 12.5±6.7
Midazolam dose*; mg 4.7±0.4
Biopsy performed; No. (%) 78 (26)
Table 2. Characteristics of the subjects (n=300)
*Plus-minus values are means±SD. 
Multivariate OR* (95% CI
� ) p-value
�
Preprocedural anxiety  -0.09
� 0.035
Apprehension about procedure 1.03 (1.00-1.06) 0.046
Recollection of procedure 1.09 (1.05-1.13) <0.0001
Pain during procedure -0.21
� 0.0004
Two word test: 30 sec after  1.05 (1.02-1.08) 0.0003
midazolam injection
Two word test: Immediately after  1.05 (1.03-1.09) 0.0002
procedure
Two word test: 30 min after  1.04 (1.01-1.07) 0.008
procedure 
Patient’s consciousness -0.25
� <0.0001
Patient’s cooperation -0.02
� 0.71
Retching 1.03 (1.00-1.06) 0.024
Patient's behavioral interruption 0.98 (0.93-1.02) 0.31
Table 4. Analysis of the data by ‘‘age’’ factor (n=300)
*OR denotes odds ratio; 
� CI denotes confidence interval; 
�
p values are
for the relationship between the data and the age; 
�
Spearman’s corre-
lation coefficient.Factors Related with Sedation 539
Slender subjects (p=0.0495) interrupted the procedure more
often because of their hyperactive and irritable behavior. High-
er preprocedural anxiety level was proportionally related to
increased consciousness during the procedure (Table 5). Apart
from consciousness, the degree of perceived pain was higher
in younger subjects (p=0.0004). Those who revealed a high
preprocedural anxiety level complained of much more severe
pain (Table 5). 
DISCUSSION
Data from the present study demonstrates that age is the
most outstanding factor in conscious sedation. Older subjects
generally had a limited understanding of the procedure and
showed less anxiety about the procedure. They were easily
sedated and exhibited few signs of retching. After the proce-
dure, they complained of little pain and did not remember
the procedure compared to younger subjects. This is consis-
tent with a previous study that reports older age is associated
with greater patient satisfaction (8). Previous studies report-
ed that midazolam elimination half-life (t1/2) is significantly
prolonged in the elderly and midazolam clearance is known
to be significantly higher in younger subjects (9, 10). It is
also known that, under adequate surveillance, the benefits in
terms of tolerance to the procedure of low dose midazolam
for gastrointestinal sedation outbalance the risks in older peo-
ple (11). This means that lower doses of midazolam are need-
ed to reach sedation in older subjects.
The issues of tolerance in conscious sedation appear to deal
primarily with anxiety and apprehension. In our study, pre-
procedural anxiety level was an independent predictive factor
for level of sedation and tolerance. Those subjects with high
preprocedural anxiety levels complained of much more severe
pain and were not easily sedated during the procedure. Females
showed higher preprocedural anxiety levels as was reported
in a previous study (12, 13). Concerning body mass index,
slender subjects were more hyperactive and irritable during
the procedure. This might be related with the fact that dis-
tribution volume (Vd) of midazolam is significantly increased
in obese persons, indicating disproportionate distribution of
midazolam into adipose tissue (9). Furthermore, previous
experience of conscious sedation was related with lower pre-
procedural anxiety levels in the present study. It has been
shown that individual factors such as personality, prior expe-
rience of previous procedures, and the presence of family mem-
bers influence the level of anxiety and tolerance for endoscopic
procedures (14-16). These studies have demonstrated that a
higher pre-examination anxiety score and a previous unpleas-
ant endoscopic experience are associated with a reduced tol-
erance. Although the perception of discomfort and pain may
be dependent on cultural characteristics, less anxiety is relat-
ed to greater patient satisfaction during conscious sedation
(8, 17, 18). 
The limitation of the present study is that we did not use
propofol which recently became popular in conscious seda-
tion. Another limitation is that, apart from gastroscopy exam-
ination, we included those patients who underwent both gas-
troscopy and sigmoidoscopy examinations. These subjects
were relatively more alert than those with gastroscopy exam-
inations alone. This result might be related with increased
procedural time due to sigmoidoscopy. Furthermore, it can
be explained by the fact that lower intestinal endoscopy is
associated with greater patient discomfort compared to upper
gastroscopy (8). 
In conclusion, lower doses of midazolam are needed to reach
sedation in the older subjects. Besides, those subjects with
high preprocedural anxiety levels such as women, younger
subjects, slender subjects, and those without previous expe-
rience of conscious sedation, should be observed with great
caution because they generally complain of more pain and
alertness during the procedure. These factors are predictive
of poor tolerance and may enable the identification of the
subjects who require more intense conscious sedation.
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